VolitionRx Limited (NYSE:NYSE:VNRX) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM Company Participants Scott Powell - IR Cameron Reynolds - Founder, Group CEO Tom Butera - CEO,.
VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
VolitionRx Limited (NYSE:NYSE:VNRX) Q2 2022 Earnings Conference Call August 11, 2022 08:30 AM ET Company Participants Scott Powell - IR Cameron Reynolds - CEO Dr.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.
VolitionRx (NYSE-A:VNRX) Limited said it has appointed Diagnostic Oncology CRO, LLC (DXOCRO) to undertake development and clinical validation studies for.